Biogen (BIIB) earnings

Earnings (net income) · fiscal 2025
$1.29B

Biogen (BIIB) reported net income of $1.29B in fiscal 2025 (the year ended December 31, 2025). That is 20.8% lower than the $1.63B of fiscal 2024. Figures as of 18 Nov 2026, 04:57 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings (net income), fiscal 2025
$1.29B
Change on fiscal 2024
−20.8%
Growth, 5 years
−20.2% a year
Growth, 10 years
−9.6% a year
Highest on record
$5.89Bfiscal 2019
Lowest on record
$638.17Mfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Biogen earnings, in more detail

Over the five fiscal years to 2025 net income shrank at a compound 20.2% a year; over ten years the rate was −9.6% a year. Across the 19 fiscal years on record (2007–2025), the highest was $5.89B in fiscal 2019 and the lowest $638.17M in fiscal 2007.

History · 19 fiscal years

Earnings (net income) by fiscal year

Biogen earnings, year by year

Biogen (BIIB) earnings by fiscal year
Fiscal yearEarnings (net income)ChangeYear ended
2025$1.29B 20.8% down
2024$1.63B 40.6% up
2023$1.16B 61.9% down
2022$3.05B 95.8% up
2021$1.56B 61.1% down
2020$4.00B 32.1% down
2019$5.89B 32.9% up
2018$4.43B 74.5% up
2017$2.54B 31.4% down
2016$3.70B 4.4% up
2015$3.55B 20.9% up
2014$2.93B 57.6% up
2013$1.86B 34.9% up
2012$1.38B 11.8% up
2011$1.23B 22.8% up
2010$1.01B 3.6% up
2009$970.13M 23.9% up
2008$783.17M 22.7% up
2007$638.17M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

How to read it

Compare it across years rather than in isolation — one-off gains and write-downs can swing a single year a long way.

Earnings (net income) at health care companies of similar size

Earnings (net income) of Biogen and comparable companies
CompanyEarnings (net income)Fiscal year
Royalty Pharma RPRX$770.95M2025
Biogen BIIB$1.29B2025
GE HealthCare Technologies GEHC$2.08B2025
Alcon ALC$980.00M2025
Mettler-Toledo International MTD$869.19M2025
Centene CNC-$6.67B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIIB

Biogen, figure by figure

Biogen (BIIB) overview: price, valuation and scorecardAll health care companies by market value

Biogen earnings: questions and answers

What is Biogen's net income?

Biogen (BIIB) reported net income of $1.29B in fiscal 2025 (the year ended December 31, 2025). That is 20.8% lower than the $1.63B of fiscal 2024.

What is the growth rate of Biogen's net income?

Over the five fiscal years to 2025 net income shrank at a compound 20.2% a year; over ten years the rate was −9.6% a year.

What are the highest and lowest net income figures on record for Biogen?

Across the 19 fiscal years on record (2007–2025), the highest was $5.89B in fiscal 2019 and the lowest $638.17M in fiscal 2007.

How is Biogen's net income calculated?

Earnings here means net income: what is left of the year's revenue after every cost, interest and tax, as reported on the income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Biogen (BIIB) earnings”, data as of 18 November 2026. https://funkfolio.com/stock/BIIB/earnings

Underlying data: the company's filings with the SEC and Yahoo Finance.